A Study on the Intraject Instructions for Use
NCT00619554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19
Last updated 2022-11-10
Summary
This study is designed to create an instruction set simple enough to be understood by migraine subjects as they were experiencing miagraine attacks.
Conditions
- Healthy
Sponsors & Collaborators
-
Zogenix, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2007-08-31
More Related Trials
-
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
NCT01016834 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
NCT00510419 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs
NCT00620425 ·Status: COMPLETED ·Phase: PHASE1
-
Zomig - Treatment of Acute Migraine Headache in Adolescents
NCT01211145 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
NCT00442936 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants
NCT05960032 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Tolerability of Zolmitriptan Nasal Spray
NCT00617747 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
NCT00095004 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.
NCT00293657 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
NCT00660192 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines
NCT01953341 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
NCT05989048 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
NCT03275922 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Gastric Delay in Migraine Patients (3207-003)
NCT00548353 ·Status: COMPLETED ·Phase: PHASE1
-
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
NCT05028569 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Riocigaut on Migraine Attack Induction in People With Migraine
NCT05750446 ·Status: COMPLETED ·Phase: NA
-
Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
NCT04066023 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Utility of Telemedicine in the Management of Migraine
NCT01706003 ·Status: COMPLETED
-
Phase 3 Study of MAP0004 in Adult Migraineurs
NCT00623636 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
NCT00092963 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2951742 in Healthy Volunteers
NCT01337596 ·Status: COMPLETED ·Phase: PHASE1
-
Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine
NCT01462812 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Use Investigation for IMIGRAN Tablet
NCT01376141 ·Status: COMPLETED
-
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
NCT00356603 ·Status: COMPLETED ·Phase: PHASE3
-
Status Migrainosus - Differentiating Between Responders and Non-responders
NCT03066544 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2